October 2014 FDA Recall Glimepiride by Micro Labs Usa, Inc S
D-0046-2015 - Failed Stability Specifications

This Class II drug recall was voluntarily initiated by Micro Labs Usa, Inc S on October 9, 2014 for the product Glimepiride. The FDA reported the reason for recall as failed stability specifications. The product was distributed in CT, FL, MD, MS, NY and the recall is currently terminated.

Recall Number: D-0046-2015

Reason for Recall
Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Initiated
10-09-2014
Reported
11-05-2014
Quantity
11,328 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Micro Labs Usa, Inc S
CT, FL, MD, MS, NY
GLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05), Rx only, Manufactured by: Micro Labs Limited, Goa-403 722, INDIA, Manufactured for: Micro Labs USA, Inc., Princeton, NJ 08540

Batch or Lot Expiration Information

Lot# GLBG001 Exp.12/14, GLBG008 Exp. 06/15